<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Eur J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>European Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1018-4813</issn>
<issn pub-type="epub">1476-5438</issn>
<publisher>
<publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30622326</article-id>
<article-id pub-id-type="pmc">6460580</article-id>
<article-id pub-id-type="publisher-id">298</article-id>
<article-id pub-id-type="doi">10.1038/s41431-018-0298-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Biallelic sequence variants in <italic>INTS1</italic> in patients with developmental delays, cataracts, and craniofacial anomalies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Krall</surname>
<given-names>Max</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Htun</surname>
<given-names>Stephanie</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schnur</surname>
<given-names>Rhonda E.</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brooks</surname>
<given-names>Alice S.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baker</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Alba Campomanes</surname>
<given-names>Alejandra</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lamont</surname>
<given-names>Ryan E.</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gripp</surname>
<given-names>Karen W.</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<collab>Care 4 Rare Canada Consortium</collab>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schneidman-Duhovny</surname>
<given-names>Dina</given-names>
</name>
<xref ref-type="aff" rid="Aff7">7</xref>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9881-5467</contrib-id>
<name>
<surname>Innes</surname>
<given-names>A. Micheil</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mancini</surname>
<given-names>Grazia M. S.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Slavotinek</surname>
<given-names>Anne M.</given-names>
</name>
<address>
<email>anne.slavotinek@ucsf.edu</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution>Dept. Pediatrics, Division of Genetics, </institution><institution>University of California, San Francisco, </institution></institution-wrap>San Francisco, CA 94143-2711 USA </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.428467.b</institution-id><institution>GeneDx, </institution></institution-wrap>Gaithersburg, MD 20877 USA </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">000000040459992X</institution-id><institution-id institution-id-type="GRID">grid.5645.2</institution-id><institution>Department of Clinical Genetics, </institution><institution>ErasmusMC University Medical Center, </institution></institution-wrap>3015CN Rotterdam, The Netherlands </aff>
<aff id="Aff4"><label>4</label>Division of Medical Genetics, A.I. du Pont Hospital for Children/Nemours, Wilmington, DE 19803 USA </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution>Department of Ophthalmology, </institution><institution>University of California, San Francisco, </institution></institution-wrap>San Francisco, CA 94143 USA </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7697</institution-id><institution-id institution-id-type="GRID">grid.22072.35</institution-id><institution>Department of Medical Genetics and Alberta Children’s Hospital Research Institute, Cumming School of Medicine, </institution><institution>University of Calgary, </institution></institution-wrap>Calgary, Canada </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0538</institution-id><institution-id institution-id-type="GRID">grid.9619.7</institution-id><institution>School of Computer Science and Engineering, </institution><institution>The Hebrew University of Jerusalem, </institution></institution-wrap>Jerusalem, Israel </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0538</institution-id><institution-id institution-id-type="GRID">grid.9619.7</institution-id><institution>Department of Biochemistry, Institute of Life Sciences, </institution><institution>The Hebrew University of Jerusalem, </institution></institution-wrap>Jerusalem, Israel </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>8</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2019</year>
</pub-date>
<volume>27</volume>
<issue>4</issue>
<fpage>582</fpage>
<lpage>593</lpage>
<history>
<date date-type="received">
<day>22</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© European Society of Human Genetics 2019</copyright-statement>
</permissions>
<abstract id="Abs1">
<p id="Par1">The Integrator complex subunit 1 (INTS1) is a component of the integrator complex that comprises 14 subunits and associates with RPB1 to catalyze endonucleolytic cleavage of nascent snRNAs and assist RNA polymerase II in promoter-proximal pause-release on protein-coding genes. We present five patients, including two sib pairs, with biallelic sequence variants in <italic>INTS1</italic>. The patients manifested absent or severely limited speech, an abnormal gait, hypotonia and cataracts. Exome sequencing revealed biallelic variants in <italic>INTS1</italic> in all patients. One sib pair demonstrated a missense variant, p.(Arg77Cys), and a frameshift variant, p.(Arg1800Profs*20), another sib pair had a homozygous missense variant, p.(Pro1874Leu), and the fifth patient had a frameshift variant, p.(Leu1764Cysfs*16) and a missense variant, p.(Leu2164Pro). We also report additional clinical data on three previously described individuals with a homozygous, loss of function variant, p.(Ser1784*) in <italic>INTS1</italic> that shared cognitive delays, cataracts and dysmorphic features with these patients. Several of the variants affected the protein C-terminus and preliminary modeling showed that the p.(Pro1874Leu) and p.(Leu2164Pro) variants may interfere with INTS1 helix folding. In view of the cataracts observed, we performed in-situ hybridization and demonstrated expression of <italic>ints1</italic> in the zebrafish eye. We used Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 to make larvae with biallelic insertion/deletion (indel) variants in <italic>ints1</italic>. The mutant larvae developed typically through gastrulation, but sections of the eye showed abnormal lens development. The distinctive phenotype associated with biallelic variants in <italic>INTS1</italic> points to dysfunction of the integrator complex as a mechanism for intellectual disability, eye defects and craniofacial anomalies.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Clinical genetics</kwd>
<kwd>Disease model</kwd>
<kwd>Clinical genetics</kwd>
<kwd>Disease model</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© European Society of Human Genetics 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>